Evidence map›Paper›PMID 28741793›Full record

ArticleLiver international : official journal of the International Association for the Study of the Liver2018

Telomerase enzyme deficiency promotes metabolic dysfunction in murine hepatocytes upon dietary stress.

Raquel M Alves-Paiva, Sachiko Kajigaya, Xingmin Feng, Jichun Chen, Marie Desierto, Susan Wong, Danielle M Townsley, Flávia S Donaires, Adeline Bertola, Bin Gao and 2 more

Open access · greenAbstract readComparative Study
In one paragraph

Article in Liver international : official journal of the International Association for the Study of the Liver, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
0.6field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Melatonin alleviates alcoholic liver diseaseActa pharmaceutica Sinica. B · 2023
    Article
  9. Review
  10. Lipid alterations in chronic liver disease and liver cancer.JHEP reports : innovation in hepatology · 2022
    Review
  11. Review
  12. Review
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Review
  19. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 2 countries.

Raquel M Alves-PaivaDepartment of Internal Medicine, Ribeirão Preto School of Medicine, University of São Paulo, Ribeirão Preto, SP, Brazil.
Sachiko KajigayaHematology Branch, National Heart, Lung, and Blood Institute, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, MD, USA.
Xingmin FengHematology Branch, National Heart, Lung, and Blood Institute, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, MD, USA.
Jichun ChenHematology Branch, National Heart, Lung, and Blood Institute, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, MD, USA.
Marie DesiertoHematology Branch, National Heart, Lung, and Blood Institute, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, MD, USA.
Susan WongHematology Branch, National Heart, Lung, and Blood Institute, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, MD, USA.
Danielle M TownsleyHematology Branch, National Heart, Lung, and Blood Institute, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, MD, USA.
Flávia S DonairesCenter for Cell-based Therapy, São Paulo Research Foundation (FAPESP), Ribeirão Preto, SP, Brazil.
Adeline BertolaLaboratory for Liver Diseases, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, MD, USA.
Bin GaoLaboratory for Liver Diseases, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, MD, USA.
Neal S YoungHematology Branch, National Heart, Lung, and Blood Institute, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, MD, USA.
Rodrigo T CaladoDepartment of Internal Medicine, Ribeirão Preto School of Medicine, University of São Paulo, Ribeirão Preto, SP, Brazil.ORCID 0000-0002-7966-6029
National Institutes of Health · USFundação de Amparo à Pesquisa do Estado de São Paulo · BRUniversidade de São Paulo · BR

Funding

Telomeres DiseasesZIAHL006089 · NHLBI · NATIONAL HEART, LUNG, AND BLOOD INSTITUTE · PI YOUNG, NEAL S · 2010 to 2025
$26.2M
Pathogenesis and Novel Therapeutic Targets of Steatotic Liver Disease and CancerZIAAA000369 · NIAAA · NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM · PI GAO, BIN · 2009 to 2025
$23.4M
Molecular mechanisms of liver injury, repair, and immunityZIAAA000368 · NIAAA · NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM · PI GAO, BIN · 2009 to 2023
$16.1M
Mechanisms of Alcoholic Liver Disease: Dis-regulation ofZ01AA000369 · NIAAA · NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM · PI GAO, BIN · 2002 to 2008
$1.6M
Intramural NIH HHS Z01 AA000369
6 · The paper itself

Abstract

BACKGROUND &

aimsShort telomeres and genetic telomerase defects are risk factors for some human liver diseases, ranging from non-alcoholic fatty liver disease and non-alcoholic steatohepatitis to cirrhosis. In murine models, telomere dysfunction has been shown to metabolically compromise hematopoietic cells, liver and heart via the activation of the p53-PGC axis.

methodsTert- and Terc-deficient mice were challenged with liquid high-fat diet. Liver metabolic contents were analysed by CE-TOFMS and liver fat content was confirmed by confocal and electronic microscopy.

resultsTert-deficient but not Terc-deficient mice develop hepatocyte injury and frank steatosis when challenged with liquid high-fat diet. Upon high-fat diet, Tert

conclusionsOur findings indicate that in telomeropathies short telomeres are not the only molecular trigger and telomerase enzyme deficiency provokes hepatocyte metabolic dysfunction, abrogates response to environmental challenge, and causes cellular injury and steatosis, providing a mechanism for liver damage in telomere diseases.

Indexed as

Diet, High-FatEnergy MetabolismLipid MetabolismTelomere ShorteningAnimalsBlood GlucoseDisease Models, AnimalEnzyme InhibitorsFatty LiverHepatocytesLiverMaleMice, Inbred C57BLMice, KnockoutRNATelomeraseBlood GlucoseEnzyme InhibitorsRNATelomerasetelomerase RNATert protein, mouseZidovudinefatty liverhigh-fat dietmetabolic dysfunctiontelomerase-deficient liver

Identifiers

PMID28741793
PMCPMC5741503
OpenAlexW2739475816

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.